Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Roose

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
The British Journal of Psychiatry : the Journal of Mental Science|June 19, 2025
Moderators of antidepressant augmentation versus switch in the OPTIMUM randomised controlled trialHelena K Kim, Jordan F Karp, Helen Lavretsky, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 20, 2020
Experiences of American Older Adults with Pre-existing Depression During the Beginnings of the COVID-19 Pandemic: A Multicity, Mixed-Methods StudyMegan E Hamm, Patrick J Brown, Jordan F Karp, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 1, 2019
Optimizing Outcomes of Treatment-Resistant Depression in Older Adults (OPTIMUM): Study Design and Treatment Characteristics of the First 396 Participants RandomizedPilar Cristancho, Emily Lenard, Eric J Lenze, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 15, 2023
Corrigendum to Optimizing Outcomes of Treatment-Resistant Depression in Older Adults (OPTIMUM): Study Design and Treatment Characteristics of the First 396 Participants Randomized. Am J Geriatr Psychiatry 2019;27(10):1138-1152. doi: 10.1016/j.jagp.2019.04.005Pilar Cristancho, Emily Lenard, Eric J Lenze, et al.
International Journal of Geriatric Psychiatry|July 1, 2023
Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depressionBenjamin Vanderschelden, Marie Anne Gebara, Hanadi Ajam Oughli, et al.
Journal of Affective Disorders|June 26, 2024
Relationship between Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) total scores in older adults with major depressive disorder: An analysis of the OPTIMUM clinical trialHelena K Kim, Eric J Lenze, Nicholas J Ainsworth, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 18, 2022
Intravenous Ketamine for Late-Life Treatment-Resistant Depression: A Pilot Study of Tolerability, Safety, Clinical Benefits, and Effect on CognitionHanadi Ajam Oughli, Marie Anne Gebara, Adam Ciarleglio, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 29, 2024
Poor Sleep is Common in Treatment-Resistant Late-life Depression and Associated With Poorer Antidepressant Response: Findings From the OPTIMUM Clinical TrialMichael S B Mak, Marie Anne Gebara, Eric J Lenze, et al.
The New England Journal of Medicine|March 3, 2023
Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric DepressionEric J Lenze, Benoit H Mulsant, Steven P Roose, et al.
Biological Psychiatry|August 9, 2005
Mood disorders in the medically ill: scientific review and recommendationsDwight L Evans, Dennis S Charney, Lydia Lewis, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
The British Journal of Psychiatry : the Journal of Mental Science|June 19, 2025
Moderators of antidepressant augmentation versus switch in the OPTIMUM randomised controlled trialHelena K Kim, Jordan F Karp, Helen Lavretsky, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 20, 2020
Experiences of American Older Adults with Pre-existing Depression During the Beginnings of the COVID-19 Pandemic: A Multicity, Mixed-Methods StudyMegan E Hamm, Patrick J Brown, Jordan F Karp, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 1, 2019
Optimizing Outcomes of Treatment-Resistant Depression in Older Adults (OPTIMUM): Study Design and Treatment Characteristics of the First 396 Participants RandomizedPilar Cristancho, Emily Lenard, Eric J Lenze, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 15, 2023
Corrigendum to Optimizing Outcomes of Treatment-Resistant Depression in Older Adults (OPTIMUM): Study Design and Treatment Characteristics of the First 396 Participants Randomized. Am J Geriatr Psychiatry 2019;27(10):1138-1152. doi: 10.1016/j.jagp.2019.04.005Pilar Cristancho, Emily Lenard, Eric J Lenze, et al.
International Journal of Geriatric Psychiatry|July 1, 2023
Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depressionBenjamin Vanderschelden, Marie Anne Gebara, Hanadi Ajam Oughli, et al.
Journal of Affective Disorders|June 26, 2024
Relationship between Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) total scores in older adults with major depressive disorder: An analysis of the OPTIMUM clinical trialHelena K Kim, Eric J Lenze, Nicholas J Ainsworth, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 18, 2022
Intravenous Ketamine for Late-Life Treatment-Resistant Depression: A Pilot Study of Tolerability, Safety, Clinical Benefits, and Effect on CognitionHanadi Ajam Oughli, Marie Anne Gebara, Adam Ciarleglio, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 29, 2024
Poor Sleep is Common in Treatment-Resistant Late-life Depression and Associated With Poorer Antidepressant Response: Findings From the OPTIMUM Clinical TrialMichael S B Mak, Marie Anne Gebara, Eric J Lenze, et al.
The New England Journal of Medicine|March 3, 2023
Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric DepressionEric J Lenze, Benoit H Mulsant, Steven P Roose, et al.
Biological Psychiatry|August 9, 2005
Mood disorders in the medically ill: scientific review and recommendationsDwight L Evans, Dennis S Charney, Lydia Lewis, et al.
Pageof 15